Fundacion Sarda Farriol, Barcelona
Increased risk for SMI is linked to autonomic neuropathy and cardiovascular risk factors
Published in Mental Health Law Weekly, December 17th, 2005
"The prevalence of silent myocardial ischemia (SMI) seems to be above average in diabetic subjects. As routine screening is costly, identifying high-risk populations is mandatory. This study aimed to estimate the prevalence of SMI in diabetic subjects and in controls and to define the diabetic population at risk," scientists in Spain report.
A. Chico and colleagues at the Fundacion Sarda Farriol investigated "353 asymptomatic caucasian subjects (217 with diabetes and 136 controls matched by age,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
More Articles from Mental Health Law Weekly
- American Academy of Neurology
Professional society elaborates expert witness guidelines - RIKEN Brain Science Institute
ASCL1 may be associated with Parkinson disease - Scripps Research Institute, La Jolla
Acamprosate is effective in treatment of alcohol dependence - Signet Laboratories, Inc.
Availability of polyclonal hepsin antibody announced - U.S. National Institute of Mental Health
Anorexia nervosa involves complex neuronal circuitries that may be similar in obesity - Amarin Corp. plc
Significant neuroprotective effects of Miraxion reported - More from this issue of Mental Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
